位置:首页 > 蛋白库 > CUL2_MOUSE
CUL2_MOUSE
ID   CUL2_MOUSE              Reviewed;         745 AA.
AC   Q9D4H8; Q3TUR8;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2003, sequence version 2.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=Cullin-2;
DE            Short=CUL-2;
GN   Name=Cul2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J, and Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH COPS2.
RX   PubMed=11967155; DOI=10.1016/s0960-9822(02)00791-1;
RA   Yang X., Menon S., Lykke-Andersen K., Tsuge T., Xiao D., Wang X.,
RA   Rodriguez-Suarez R.J., Zhang H., Wei N.;
RT   "The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase
RT   progression via deneddylation of SCF Cul1.";
RL   Curr. Biol. 12:667-672(2002).
RN   [4]
RP   INTERACTION WITH MED8.
RX   PubMed=12149480; DOI=10.1073/pnas.162424199;
RA   Brower C.S., Sato S., Tomomori-Sato C., Kamura T., Pause A., Stearman R.,
RA   Klausner R.D., Malik S., Lane W.S., Sorokina I., Roeder R.G., Conaway J.W.,
RA   Conaway R.C.;
RT   "Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that
RT   can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:10353-10358(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-393, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: Core component of multiple cullin-RING-based ECS (ElonginB/C-
CC       CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which
CC       mediate the ubiquitination of target proteins. CUL2 may serve as a
CC       rigid scaffold in the complex and may contribute to catalysis through
CC       positioning of the substrate and the ubiquitin-conjugating enzyme. The
CC       E3 ubiquitin-protein ligase activity of the complex is dependent on the
CC       neddylation of the cullin subunit and is inhibited by the association
CC       of the deneddylated cullin subunit with TIP120A/CAND1. The functional
CC       specificity of the ECS complex depends on the substrate recognition
CC       component. ECS(VHL) mediates the ubiquitination of hypoxia-inducible
CC       factor (HIF). A number of ECS complexes (containing either KLHDC2,
CC       KLHDC3, KLHDC10, APPBP2, FEM1A, FEM1B or FEM1C as substrate-recognition
CC       component) are part of the DesCEND (destruction via C-end degrons)
CC       pathway, which recognizes a C-degron located at the extreme C terminus
CC       of target proteins, leading to their ubiquitination and degradation.
CC       ECS complexes and ARIH1 collaborate in tandem to mediate ubiquitination
CC       of target proteins. {ECO:0000250|UniProtKB:Q13617}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q13617}.
CC   -!- SUBUNIT: Component of multiple ECS (Elongin BC-CUL2/5-SOCS-box protein)
CC       E3 ubiquitin-protein ligase complexes formed of CUL2, Elongin BC (ELOB
CC       and ELOC), RBX1 and a variable substrate-specific adapter. Component of
CC       the ECS(VHL) or CBC(VHL) complex containing VHL. Component of the
CC       ECS(MED8) complex with the probable substrate recognition component
CC       MED8. Component of multiple ECS complexes part of the DesCEND
CC       (destruction via C-end degrons) pathway, which contain either KLHDC2,
CC       KLHDC3, KLHDC10, APPBP2, FEM1A, FEM1B or FEM1C as substrate-recognition
CC       component. Component of the ECS(LRR1) complex with the probable
CC       substrate recognition component LRR1. Component of a probable ECS E3
CC       ubiquitin-protein ligase complex containing CUL2, RBX1, ELOB, ELOC and
CC       FEM1B. Part of an E3 ubiquitin-protein ligase complex including ZYG11B,
CC       CUL2 and Elongin BC. Part of an E3 ubiquitin-protein ligase complex
CC       including ZER1, CUL2 and Elongin BC. Interacts with RBX1, RNF7, FEM1B
CC       and TIP120A/CAND1. Found in a complex composed of LIMD1, VHL,
CC       EGLN1/PHD2, ELOB and CUL2. Interacts (when neddylated) with ARIH1;
CC       leading to activate the E3 ligase activity of ARIH1. Interacts
CC       (unneddylated form) with DCUN1D1, DCUN1D2, DCUN1D3, DCUN1D4 and
CC       DCUN1D5; these interactions promote the cullin neddylation. Component
CC       of VCB (elongins BC/CUL2/VHL) complex that contains at least DCUN1D1,
CC       CUL2 and VHL; this complex triggers CUL2 neddylation and consequently
CC       cullin ring ligase (CRL) substrates polyubiquitylation.
CC       {ECO:0000250|UniProtKB:Q13617}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9D4H8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9D4H8-2; Sequence=VSP_008823;
CC   -!- PTM: Neddylated; which enhances the ubiquitination activity of ECS
CC       (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase
CC       complexes. CBC(VHL) complex formation seems to promote neddylation (By
CC       similarity). Deneddylated via its interaction with the COP9 signalosome
CC       (CSN) complex. {ECO:0000250|UniProtKB:Q13617}.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK016520; BAB30283.1; -; mRNA.
DR   EMBL; AK160597; BAE35903.1; -; mRNA.
DR   EMBL; BC026779; AAH26779.1; -; mRNA.
DR   EMBL; BC027428; AAH27428.1; -; mRNA.
DR   EMBL; BC025902; AAH25902.1; -; mRNA.
DR   CCDS; CCDS29032.2; -. [Q9D4H8-1]
DR   RefSeq; NP_083678.2; NM_029402.3. [Q9D4H8-1]
DR   RefSeq; XP_006526337.1; XM_006526274.3.
DR   RefSeq; XP_006526338.1; XM_006526275.3. [Q9D4H8-1]
DR   AlphaFoldDB; Q9D4H8; -.
DR   SMR; Q9D4H8; -.
DR   BioGRID; 214895; 40.
DR   IntAct; Q9D4H8; 6.
DR   MINT; Q9D4H8; -.
DR   STRING; 10090.ENSMUSP00000125403; -.
DR   iPTMnet; Q9D4H8; -.
DR   PhosphoSitePlus; Q9D4H8; -.
DR   EPD; Q9D4H8; -.
DR   jPOST; Q9D4H8; -.
DR   MaxQB; Q9D4H8; -.
DR   PaxDb; Q9D4H8; -.
DR   PeptideAtlas; Q9D4H8; -.
DR   PRIDE; Q9D4H8; -.
DR   ProteomicsDB; 279209; -. [Q9D4H8-1]
DR   ProteomicsDB; 279210; -. [Q9D4H8-2]
DR   Antibodypedia; 3631; 502 antibodies from 42 providers.
DR   DNASU; 71745; -.
DR   Ensembl; ENSMUST00000025073; ENSMUSP00000025073; ENSMUSG00000024231. [Q9D4H8-2]
DR   Ensembl; ENSMUST00000162301; ENSMUSP00000125403; ENSMUSG00000024231. [Q9D4H8-1]
DR   GeneID; 71745; -.
DR   KEGG; mmu:71745; -.
DR   UCSC; uc008dxz.2; mouse. [Q9D4H8-2]
DR   UCSC; uc008dya.2; mouse. [Q9D4H8-1]
DR   CTD; 8453; -.
DR   MGI; MGI:1918995; Cul2.
DR   VEuPathDB; HostDB:ENSMUSG00000024231; -.
DR   eggNOG; KOG2284; Eukaryota.
DR   GeneTree; ENSGT00940000154926; -.
DR   HOGENOM; CLU_004747_6_1_1; -.
DR   InParanoid; Q9D4H8; -.
DR   OMA; WRLYMIE; -.
DR   OrthoDB; 1040292at2759; -.
DR   PhylomeDB; Q9D4H8; -.
DR   TreeFam; TF101152; -.
DR   Reactome; R-MMU-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 71745; 23 hits in 73 CRISPR screens.
DR   ChiTaRS; Cul2; mouse.
DR   PRO; PR:Q9D4H8; -.
DR   Proteomes; UP000000589; Chromosome 18.
DR   RNAct; Q9D4H8; protein.
DR   Bgee; ENSMUSG00000024231; Expressed in superior cervical ganglion and 265 other tissues.
DR   ExpressionAtlas; Q9D4H8; baseline and differential.
DR   Genevisible; Q9D4H8; MM.
DR   GO; GO:0031462; C:Cul2-RING ubiquitin ligase complex; IDA:MGI.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0030891; C:VCB complex; ISO:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
DR   GO; GO:0030163; P:protein catabolic process; IMP:MGI.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR045093; Cullin.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11932; PTHR11932; 1.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Isopeptide bond; Phosphoprotein;
KW   Reference proteome; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN           1..745
FT                   /note="Cullin-2"
FT                   /id="PRO_0000119791"
FT   MOD_RES         393
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         661
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13617"
FT   CROSSLNK        689
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in NEDD8)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13616"
FT   VAR_SEQ         664..702
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_008823"
FT   CONFLICT        612
FT                   /note="K -> R (in Ref. 1; BAB30283)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   745 AA;  86877 MW;  311C05CC262692E0 CRC64;
     MSLKPRVVDF DETWNKLLTT IKAVVMLEYV ERATWNDRFS DIYALCVAYP EPLGERLYAE
     TKIFLESHVR HLYKRVLESE EQVLVMYHRY WEEYSKGADY MDCLYRYLNT QYIKKNKLTE
     ADIQYGYGGV DMNEPLMEIG ELALDMWRKL MVEPLQNILI RMLLREIKND RGGEDPNQKV
     IHGVINSFVH VEQYKKKFPL KFYQGIFVSP FLTETGEYYK QEASNLLQES NCSQYMEKVL
     GRLKDEEIRC RKYLHPSSYT KVIHECQQRM VADHLQFLHS ECHSIIQQER KNDMANMYVL
     LRAVSSGLPH MIEELQKHIH DEGLRATSNL TQEHMPTLFV ESVLEVHGKF VQLINTVLNG
     DQHFMSALDK ALTSVVNYRE PKSVCKAPEL LAKYCDNLLK KSAKGMTENE VEDKLTSFIT
     VFKYIDDKDV FQKFYARMLA KRLIHGLSMS MDSEEAMINK LKQACGYEFT SKLHRMYTDM
     SVSADLNNKF NNFIRNQDTV IDLGISFQIY VLQAGAWPLT QAPSSTFAIP QELEKSVQMF
     ELFYSQHFSG RKLTWLHYLC TGEVKMNYLG KPYVAMVTTY QMAVLLAFNN SETVSYKELQ
     DSTQMNEKEL TKTIKSLLDV KMINHDSEKE DIDAESSFSL NMSFSSKRTK FKITTSMQKD
     TPQELEQTRS AVDEDRKMYL QAAIVRIMKA RKVLRHNALI QEVISQSRAR FNPSISMIKK
     CIEVLIDKQY IERSQASADE YSYVA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025